{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:03:56Z","timestamp":1790233436246,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejrad.2026.113167","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:23:22Z","timestamp":1787153002000},"page":"113167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Initial drug-eluting beads transarterial chemoembolization using hepaspheres in patients with large (\u22655 cm) hepatocellular carcinoma"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3121-2853","authenticated-orcid":false,"given":"Dong Il","family":"Gwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Ho","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gun Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Soo","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ki","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.113167_b0005","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol 56 (4) (2012) 893\u2013903, Doi:10.1016\/j.jhep.2011.12.001. PMID:22424438.","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"10.1016\/j.ejrad.2026.113167_b0010","doi-asserted-by":"crossref","unstructured":"R. Iezzi, T. Bilhim, L. Crocetti, B. Peynircioglu, S. Goldberg, J. I. Bilbao, A. Sami, O. Akhan, P. Scalise, F. Giuliante, M. Pompili, V. Valentini, A. Gasbarrini, C. Colosimo, R. Manfredi, \u201cPrimum non nocere\u201d in interventional oncology for liver cancer: how to reduce the risk for complications? Life 10 (9) (2020) 10:180, Doi:10.3390\/life10090180. PMID:32899925.","DOI":"10.3390\/life10090180"},{"key":"10.1016\/j.ejrad.2026.113167_b0015","doi-asserted-by":"crossref","unstructured":"M. Lee, J.W. Chung JW, K.H. Lee, J.Y. Won, H.J. Chun, H.C. Lee, J.H. Kim, I.J. Lee, S. Hur, H.C. Kim, Y.J. Kim, G.M. Kim, S.M. Joo, J.S. Oh, Korean multicenter registry of transcatheter arterial chemoembolization with drug-eluting embolic agents for nodular hepatocellular carcinoma: six-month outcome analysis. J Vasc Interv Radiol 28 (4) (2017) 502\u2013512, Doi:10.1016\/j.jvir.2016.08.017. PMID:27856136.","DOI":"10.1016\/j.jvir.2016.08.017"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","article-title":"Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for nodular hepatocellular carcinoma","volume":"26","author":"Vesselle","year":"2016","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113167_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jgh.13501","article-title":"Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: emphasis on the impact of tumor size","volume":"32","author":"Lee","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113167_b0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2214\/AJR.19.21669","article-title":"Drug-eluting microsphere versus cisplatin-based transarterial chemoembolization for the treatment of hepatocellular carcinoma: propensity score-matched analysis","volume":"215","author":"Chu","year":"2020","journal-title":"AJR Am. J. Roentgenol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"57","author":"Song","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2026.113167_b0045","article-title":"Evaluation of the safety and efficacy of conventional transarterial chemoembolization (cTACE) and drug-eluting bead (DEB)-TACE in the management of unresectable hepatocellular carcinoma: a systematic review","volume":"15","author":"Ayyub","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113167_b0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"90Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2026.113167_b0055","doi-asserted-by":"crossref","unstructured":"N.H. Phan, H.J. Chun, J.S. Oh, S.H. Kim, B.G. Choi, TACE vs. TARE for HCC \u22658cm: a propensity score analysis. Abdominal Radiology 50 (3) 2025 1198\u20131208, Doi:10.1007\/s00261-024-04573-5. PMID:39320494.","DOI":"10.1007\/s00261-024-04573-5"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113167_b0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/liv.12637","article-title":"In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?","volume":"35","author":"El Fouly","year":"2015","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113167_b0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/life11040358","article-title":"Initial transarterial chemoembolization (TACE) using hepasphere 20-40 um and subsequent lipiodol TACE in patients with hepatocellular carcinoma > 5 cm","volume":"11","author":"Cho","year":"2021","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0070","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-008-9409-2","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study","volume":"31","author":"Grosso","year":"2008","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113167_b0075","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00270-010-0044-3","article-title":"Safety profile of sequential transcatheter chemoembolization with DC beadTM : results of 237 hepatocellular carcinoma (HCC) patients","volume":"34","author":"Malagari","year":"2011","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0080","doi-asserted-by":"crossref","first-page":"W706","DOI":"10.2214\/AJR.13.12308","article-title":"Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC","volume":"203","author":"Prajapati","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3348\/kjr.2018.0088","article-title":"Update on transarterial chemoembolization with drug-eluting microspheres for hepatocellular carcinoma","volume":"20","author":"Nouri","year":"2019","journal-title":"Korean J. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2026.113167_b0090","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jvir.2017.07.020","article-title":"Transarterial chemoembolization with small drug-eluting beads in patients with hepatocellular carcinoma: experience from a cohort of 421 patients at an Italian center","volume":"28","author":"Aliberti","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2026.113167_b0095","doi-asserted-by":"crossref","unstructured":"K. Malagari, M. Pomoni, H. Moschouris, A. Kelekis, A. Charokopakis, E. Bouma, T. Spyridopoulos, A. Chatziioannou, V. Sotirchos, T. Karampelas, C. Tamvakopoulos, D. Filippiadis, E. Karagiannis, A. Marinis, J. Koskinas, D.A. Kelekis, Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 \u03bcm. Safety and efficacy study. Cardiovasc Intervent Radiol 37 (1) (2014) 165\u2013175, Doi:10.1007\/s00270-013-0777-x. PMID:24263774.","DOI":"10.1007\/s00270-013-0777-x"},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0105","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","article-title":"Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma","volume":"26","author":"Vesselle","year":"2016","journal-title":"Eur. Radiol."},{"issue":"11","key":"10.1016\/j.ejrad.2026.113167_b0110","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jvir.2015.07.017","article-title":"A single-center retrospective comparison of doxorubicin-loaded HepaSphere transarterial chemoembolization with conventional transarterial chemoembolization for patients with unresectable hepatocellular carcinoma","volume":"26","author":"Kucukay","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12957-020-02017-0","article-title":"The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis","volume":"18","author":"Cheng","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0120","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jceh.2021.02.003","article-title":"Survival and outcome in patients receiving drug-eluting beads transarterial chemoembolization for large hepatocellular carcinoma (>5 cm)","volume":"11","author":"Mukund","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0125","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/10717544.2021.1943057","article-title":"Assessment of efficacy and safety by calliSpheres versus hepaspheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinnoma patients","volume":"28","author":"Zhao","year":"2021","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113167_b0130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/hepr.13620","article-title":"Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug-eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma","volume":"51","author":"Chen","year":"2021","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113167_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.crad.2018.12.008","article-title":"Time-to-progression following conventional compared with drug-eluting-bead transcatheter arterial chemoembolisation in patients with large hepatocellular carcinoma","volume":"74","author":"Ou","year":"2019","journal-title":"Clin. Radiol."},{"issue":"9","key":"10.1016\/j.ejrad.2026.113167_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12957-021-02188-4","article-title":"Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis","volume":"19","author":"Jiang","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.ejrad.2026.113167_b0145","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00270-019-02260-3","article-title":"Five-years outcome analysis of 142 consecutive hepatocellular carcinoma patients treated with doxorubicin eluting microscpheres 30-60 \u03bcm: results from a single-centre prospective phase II trial","volume":"42","author":"Malagari","year":"2019","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0150","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s00330-015-3982-y","article-title":"Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma","volume":"26","author":"Vesselle","year":"2016","journal-title":"Eur. Radiol."},{"issue":"7","key":"10.1016\/j.ejrad.2026.113167_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11604-019-00840-4","article-title":"Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE)","volume":"37","author":"Nakano","year":"2019","journal-title":"Jpn. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113167_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.18632\/oncotarget.13427","article-title":"Hepatic resection after transarterial chemoembolization increases overall survival in large\/multifocal hepatocellular carcinoma: a retrospective cohort study","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.ejrad.2026.113167_b0165","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1002\/cam4.5529","article-title":"Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (\u22655 cm): multicenter retrospective study","volume":"12","author":"Mo","year":"2023","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113167_b0170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12072-019-09981-0","article-title":"Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (\u226510 cm): a multicenter propensity matching analysis","volume":"13","author":"Li","year":"2019","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113167_b0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4174\/astr.2025.109.3.194","article-title":"Limited survival benefit of preoperative transarterial chemoembolization in huge hepatocellular carcinoma due to the prognostic impact of satellite nodules: a retrospective cohort study","volume":"109","author":"Na","year":"2025","journal-title":"Ann Sur Treat Res"},{"issue":"7","key":"10.1016\/j.ejrad.2026.113167_b0180","article-title":"Evaluation of the safety and efficacy of conventional transarterial chemoembolization (cTACE) and drug-eluting bead (DEB)-TACE in the management of unresectable hepatocellular carcinoma: a systematic review","volume":"15","author":"Ayyub","year":"2023","journal-title":"Cureus"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26005152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:46:19Z","timestamp":1790232379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26005152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0720048X26005152"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113167","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial drug-eluting beads transarterial chemoembolization using hepaspheres in patients with large (\u22655 cm) hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113167"}}